Impax Asset Management Group plc Sells 6,049 Shares of CME Group Inc. $CME

Impax Asset Management Group plc decreased its stake in shares of CME Group Inc. (NASDAQ:CME) by 9.6% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 56,672 shares of the financial services provider’s stock after selling 6,049 shares during the period. Impax Asset Management Group plc’s holdings in CME Group were worth $15,312,000 as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. Empowered Funds LLC increased its stake in shares of CME Group by 11.5% during the first quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock worth $2,660,000 after purchasing an additional 1,037 shares during the period. Johnson Investment Counsel Inc. bought a new position in CME Group during the 2nd quarter worth $289,000. MGO One Seven LLC increased its position in CME Group by 19.9% during the 2nd quarter. MGO One Seven LLC now owns 6,553 shares of the financial services provider’s stock worth $1,806,000 after buying an additional 1,089 shares during the period. Total Clarity Wealth Management Inc. acquired a new stake in shares of CME Group during the second quarter worth $230,000. Finally, Sequoia Financial Advisors LLC boosted its position in shares of CME Group by 5.9% in the second quarter. Sequoia Financial Advisors LLC now owns 11,196 shares of the financial services provider’s stock valued at $3,086,000 after acquiring an additional 627 shares during the period. 87.75% of the stock is owned by institutional investors.

Trending Headlines about CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME launched futures for Cardano, Chainlink and Stellar — expanding its crypto product suite and giving institutional traders additional regulated venues, which can drive incremental trading and clearing fees. CME Group Announces First Trades for New Cardano, Chainlink and Stellar Cryptocurrency Futures
• Positive Sentiment: CME plans to launch Single Stock futures on 50+ top U.S. names (Alphabet, Meta, NVIDIA, Tesla, etc.), broadening product scope and offering capital-efficient tools for equity exposures — potential long-term fee diversification. CME Group to Launch Single Stock Futures
• Positive Sentiment: Sources say CME is exploring the first-ever rare earths futures contract — a new commodity product that could capture demand tied to EVs, clean energy and defense supply-chain hedging. CME Group plans to launch first rare earths futures contract – Reuters
• Positive Sentiment: Wedbush highlighted strong clearing volumes in CME’s prediction markets around Super Bowl LX — an operational sign that new product adoption is producing meaningful flow spikes. Wedbush Supports CME Group Prediction Markets as Volumes Surge Around Super Bowl LX
• Positive Sentiment: Institutional buying — Illinois Municipal Retirement Fund increased its CME position (~38k shares, ~65% growth vs prior), signaling continued institutional demand. Fund Update: Illinois Municipal Retirement Fund Just Disclosed New Holdings
• Neutral Sentiment: Analyst / earnings follow-ups — Q4 analyst-question coverage and commentary highlight execution and growth drivers but contain no new guidance; useful for modeling but not immediately price-moving. 5 Must-Read Analyst Questions From CME Group’s Q4 Earnings Call
• Neutral Sentiment: Crypto market write-ups note CME’s crypto futures launches as a tailwind for underlying token interest, but crypto price moves are separate from CME’s fee-based revenue. Cardano price forecast: will ADA breakout or decline further from here?
• Negative Sentiment: Insider selling — Director Dennis Suskind sold 748 shares (~$224k); multiple recent insider sales can be interpreted by some investors as a cautionary signal. SEC Form 4: Dennis Suskind sale
• Negative Sentiment: Rising short interest — recent data showed short interest increased to ~5.2M shares (≈1.4% of float, ~2.8 days-to-cover), which can add downward pressure if sentiment deteriorates further.
• Negative Sentiment: Goldman Sachs nudged its price target to $266 but maintained a sell rating — a notable institutional view that may limit near-term buying interest from some investors. The Goldman Sachs Group Increases CME Group Price Target to $266

CME Group Price Performance

Shares of CME stock opened at $302.48 on Thursday. The business has a fifty day simple moving average of $278.61 and a 200 day simple moving average of $273.60. The company has a market cap of $109.07 billion, a P/E ratio of 27.10, a P/E/G ratio of 3.34 and a beta of 0.27. The company has a quick ratio of 1.02, a current ratio of 1.03 and a debt-to-equity ratio of 0.12. CME Group Inc. has a twelve month low of $244.43 and a twelve month high of $309.35.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, February 4th. The financial services provider reported $2.77 EPS for the quarter, topping the consensus estimate of $2.75 by $0.02. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The firm had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the previous year, the firm earned $2.52 earnings per share. The business’s quarterly revenue was up 8.1% on a year-over-year basis. On average, sell-side analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year.

Insider Activity at CME Group

In other news, Director William R. Shepard bought 251 shares of the company’s stock in a transaction on Tuesday, December 30th. The stock was purchased at an average cost of $278.37 per share, for a total transaction of $69,870.87. Following the completion of the transaction, the director owned 258,710 shares of the company’s stock, valued at $72,017,102.70. This trade represents a 0.10% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Dennis Suskind sold 748 shares of CME Group stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $300.00, for a total value of $224,400.00. Following the sale, the director directly owned 2,699 shares in the company, valued at $809,700. The trade was a 21.70% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.30% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several brokerages have weighed in on CME. Piper Sandler lifted their price objective on shares of CME Group from $296.00 to $313.00 and gave the stock an “overweight” rating in a research note on Thursday, November 13th. TD Cowen lifted their price target on shares of CME Group from $305.00 to $328.00 and gave the company a “buy” rating in a research report on Thursday, February 5th. Royal Bank Of Canada boosted their price target on CME Group from $295.00 to $302.00 and gave the company a “sector perform” rating in a research note on Thursday, February 5th. Deutsche Bank Aktiengesellschaft raised their price objective on CME Group from $312.00 to $316.00 and gave the stock a “buy” rating in a research note on Thursday, February 5th. Finally, Weiss Ratings reaffirmed a “buy (b+)” rating on shares of CME Group in a report on Monday, December 29th. Nine equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $297.59.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.